Enhancing the QUAlity and Transparency Of health Research

Search for reporting guidelines

Use your browser's Back button to return to your search results

Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research -The ConPhy MP-Guidelines

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
Reporting the chemical composition of medicinal plant extracts used in pharmacological, toxicological and clinical research studies.
Full bibliographic reference Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kulić Ž, McGaw LJ, Pezzuto JM, Potterat O, Wang JB. Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines. Front Pharmacol. 2022;13:953205.
Language English
PubMed ID 36176427
Relevant URLs
(full-text if available)
Read the full-text of the ConPhyMP reporting guideline.
Reporting guideline acronym ConPhyMP
Study design Clinical trials, Experimental studies
Clinical area Complementary and alternative medicine, Pharmaceutical medicine, Toxicology
Applies to the whole report or to individual sections of the report? Harms/adverse effects/safety data, Intervention (exposure), Terminology/definitions
Additional information An online fillable open-access ConPhyMP tool is also available via the GA (Society of Medicinal Plants and Natural Products Research) website at https://ga-online.org/best-practice/

 
Record last updated on August 16, 2023

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.